Document Detail


Variants of the adenosine A(2A) receptor gene are protective against proliferative diabetic retinopathy in patients with type 1 diabetes.
MedLine Citation:
PMID:  21088442     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIMS: The adenosine A(2A) receptor (ADORA(2A)) may ameliorate deleterious physiologic effects associated with tissue injury in individuals with diabetes. We explored associations between variants of the ADORA(2A) gene and proliferative diabetic retinopathy (PDR) in a cohort of patients with type 1 diabetes (T1D).
METHODS: The participants were from the Pittsburgh Epidemiology of Diabetes Complications prospective study of childhood-onset T1D. Stereoscopic photographs of the retinal fundus taken at baseline, then biennially, for 10 years were used to define PDR according to the modified Airlie House system. Two tagging single nucleotide polymorphisms (tSNPs; rs2236624-C/T and rs4822489-G/T) in the ADORA(2A) gene were selected using the HapMap (haplotype map) reference database.
RESULTS: A significant association was observed between SNP rs2236624 and PDR in the recessive genetic model. Participants homozygous for the T allele displayed a decreased risk of developing prevalent PDR (odds ratio, OR = 0.36; p = 0.04) and incident PDR (hazard ratio = 0.156; p = 0.009), and for all cases of PDR combined (OR = 0.23; p = 0.001). The protective effect of T allele homozygosity remained after adjusting for covariates. Similarly, for SNP rs4822489, an association between PDR and T allele homozygosity was observed following covariate adjustment (OR = 0.55; 95% CI: 0.31-0.92; p = 0.04).
CONCLUSION: Genetic variants of ADORA(2A) offer statistically significant protection against PDR development in patients with T1D.
Authors:
Bashira A Charles; Yvette P Conley; Guanjie Chen; Rachel G Miller; Janice S Dorman; Michael B Gorin; Robert E Ferrell; Susan M Sereika; Charles N Rotimi; Trevor J Orchard
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't     Date:  2010-11-19
Journal Detail:
Title:  Ophthalmic research     Volume:  46     ISSN:  1423-0259     ISO Abbreviation:  Ophthalmic Res.     Publication Date:  2011  
Date Detail:
Created Date:  2011-06-16     Completed Date:  2011-10-13     Revised Date:  2012-04-11    
Medline Journal Info:
Nlm Unique ID:  0267442     Medline TA:  Ophthalmic Res     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  1-8     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 S. Karger AG, Basel.
Affiliation:
Center for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892-5635, USA. charlesba@mail.nih.gov
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Diabetes Mellitus, Type 1 / genetics*
Diabetic Retinopathy / genetics*,  prevention & control
Female
Genotype
Humans
Male
Polymerase Chain Reaction
Polymorphism, Single Nucleotide*
Prospective Studies
Receptor, Adenosine A2A / genetics*
Retinal Neovascularization / genetics*,  prevention & control
Young Adult
Grant Support
ID/Acronym/Agency:
1F31NR008970-01A2/NR/NINR NIH HHS; R01 DK034818-21/DK/NIDDK NIH HHS; Z01HG200362/HG/NHGRI NIH HHS
Chemical
Reg. No./Substance:
0/Receptor, Adenosine A2A

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Developmental factors of fibrous opacification in the atopic cataract lens capsule.
Next Document:  Acute Spiral Ganglion Cell Degeneration following Acoustic Overstimulation: An Experimental Study.